Abstract

Equine Cushing's Disease: A Clinical Update

Author(s): Bliss George

Issue: Sep/Oct 2007 - Veterinary Compounding

Page(s): 384-388

Download in electronic PDF format for $75
  • Equine Cushing's Disease: A Clinical Update Page 1
  • Equine Cushing's Disease: A Clinical Update Page 2
  • Equine Cushing's Disease: A Clinical Update Page 3
  • Equine Cushing's Disease: A Clinical Update Page 4
  • Equine Cushing's Disease: A Clinical Update Page 5

Abstract

The Department of Pharmacology at the North Carolina State University College of Veterinary Medicine is currently conducting stability studies of oral suspensions of pergolide for the treatment of equine Cushing’s disease. While those results are not available at this time, this paper summarizes the results of a literature search on possible clinical treatments for equine Cushing’s and is intended to provide insight into the pathophysiology of the disease. Pharmacological options for treatment of equine Cushing’s are discussed.

Related Keywords

  • horses
  • veterinary compounding
  • Cushing's disease
  • endocrine disorders
  • pergolide
  • formulations
  • cortisol
  • hypercortisolism
  • PPID
  • pituitary pars intermedia dysfunction
  • adrenal disorders
  • pituitary disorders
  • cyproheptadine
  • serotonin antagonist
  • ACTH
  • trilostane
  • 3-beta hydroxysteroid dehydrogenase inhibitor
  • literature review

Related Categories

  • FORMULATIONS
  • VETERINARY
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2007
Pg. 384-388
Equine Cushing's Disease: A Clinical Update
Author(s): Bliss George
Jan/Feb 2003
Pg. 27-29
Equine Cushing’s Syndrome
Author(s): Vail Jane
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jul/Aug 2005
Pg. 275-278
Compounding for Endocrine Disorders in Adult Patients
Author(s): Grajeda Betty Jo, Vail Jane
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 1997
Pg. 242-243
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Jan/Feb 2013
Pg. 39-44
Adrenal Fatigue
Author(s): Allen Loyd V Jr
Sep/Oct 2002
Pg. 332-336
Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Author(s): Davidson Gigi S
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
May/Jun 2005
Pg. 231
Pergolide 500-mcg Capsules, Veterinary
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 232
Pergolide 0.2-mg/mL Oral Liquid, Veterinary
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 87-89
Attention Deficit Hyperactivity Disorder
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn